|Articles|September 15, 2002
- BioPharm International-09-01-2002
- Volume 15
- Issue 9
Attack Mounts on Pharmaceutical Prices
Author(s)Jill Wechsler
by Jill Wechsler. Pressure to enact an affordable Medicare drug benefit is driving legislation that threatens patent protections and boosts cheap imports.
Advertisement
Articles in this issue
about 23 years ago
Reexamining the Set It and Forget It Approachabout 23 years ago
Security in the Corporate Homelandabout 23 years ago
Integrating New Technology into Blood Plasma Fractionationabout 23 years ago
If a Tree Fell in the ForestNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
